Literature DB >> 14980007

Ginsenoside-Rd attenuates oxidative damage related to aging in senescence-accelerated mice.

Takako Yokozawa1, Akiko Satoh, Eun Ju Cho.   

Abstract

Among the various theories of the aging process, the free radical theory, which proposes that deleterious actions of free radicals are responsible for the functional deterioration associated with aging, has received widespread attention. The theory suggests that enhancement of the antioxidative defence system to attenuate free-radical-induced damage will counteract the aging process. We used senescence-accelerated mice (SAM) to investigate the relationship between aging and the antioxidative defence system and evaluated the effects of ginsenoside-Rd, the saponin from ginseng, by measuring antioxidative defence system parameters, including the glutathione (GSH)/glutathione disulfide (GSSG) redox status, antioxidative enzyme activity and level of lipid peroxidation. SAM at 11 months of age (old SAM) showed a significantly lower hepatic GSH/GSSG ratio, due to decreased GSH and increased GSSG levels, than SAM at 5 weeks of age (young SAM). However, the administration of ginsenoside-Rd at a dose of 1 or 5 mg kg(-1) daily for 30 days to 10-month-old SAM significantly increased GSH, but decreased GSSG, resulting in elevation of the GSH/GSSG ratio. In addition, ginsenoside-Rd increased the activity of glutathione peroxidase (GSH-Px) and glutathione reductase that were both significantly lower in old SAM than in young SAM. This suggests that ginsenoside-Rd could play a crucial role in enhancing the defence system through regulation of the GSH/GSSG redox status. Moreover, decreases in the superoxide dismutase (SOD) and catalase activity in old SAM compared with young SAM were also revealed, indicating that the aging process resulted in suppression of the antioxidative defence system. However, ginsenoside-Rd did not affect SOD and catalase activity. As catalase is localized in peroxisome granules and GSH-Px is present in the cytoplasm and mitochondrial matrix, the site of ginsenoside-Rd action may be the cytoplasm and mitochondrial matrix. Furthermore, the serum and liver malondialdehyde levels, indicators of lipid peroxidation, were elevated with aging, while ginsenoside-Rd inhibited lipid peroxidation. This study indicates that the aging process leads to suppression of the antioxidative defence system and accumulation of lipid peroxidation products, while ginsenoside-Rd attenuates the oxidative damage, which may be responsible for the intervention of GSH/GSSG redox status.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980007     DOI: 10.1211/0022357022449

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  21 in total

1.  UVB induced oxidative stress in human keratinocytes and protective effect of antioxidant agents.

Authors:  Guang-Hui Jin; Yang Liu; Shun-Zi Jin; Xiao-Dong Liu; Shu-Zheng Liu
Journal:  Radiat Environ Biophys       Date:  2007-02-06       Impact factor: 1.925

2.  Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia.

Authors:  Yunxia Zhang; Linfu Zhou; Xiao Zhang; Jiuxu Bai; Ming Shi; Gang Zhao
Journal:  Neurol Sci       Date:  2012-01-10       Impact factor: 3.307

Review 3.  Ginseng compounds: an update on their molecular mechanisms and medical applications.

Authors:  Jian-Ming Lü; Qizhi Yao; Changyi Chen
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

4.  Ginsennoside rd attenuates cognitive dysfunction in a rat model of Alzheimer's disease.

Authors:  Juanfang Liu; Xiaodong Yan; Ling Li; Yi Zhu; Kefeng Qin; Linfu Zhou; Dong Sun; Xiaohui Zhang; Ruidong Ye; Gang Zhao
Journal:  Neurochem Res       Date:  2012-08-18       Impact factor: 3.996

5.  In vitro antioxidant properties of a ginseng intestinal metabolite IH-901.

Authors:  Nam-Jin Lee; Jung Won Lee; Jong Hwan Sung; Young-Jung Lee; Jong-Koo Kang
Journal:  Lab Anim Res       Date:  2011-09-30

6.  Antioxidants as a preventive treatment for epileptic process: a review of the current status.

Authors:  Boštjan Martinc; Iztok Grabnar; Tomaž Vovk
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

Review 7.  Development of Facial Rejuvenation Procedures: Thirty Years of Clinical Experience with Face Lifts.

Authors:  Byung Jun Kim; Jun Ho Choi; Yoonho Lee
Journal:  Arch Plast Surg       Date:  2015-09-15

8.  Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver.

Authors:  Dae Hyun Kim; Jae Heun Chung; Ji Sung Yoon; Young Mi Ha; Sungjin Bae; Eun Kyeong Lee; Kyung Jin Jung; Min Sun Kim; You Jung Kim; Mi Kyung Kim; Hae Young Chung
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

9.  Effects of ginsenosides Re and Rg3 on intracellular redox state and cell proliferation in C6 glioma cells.

Authors:  Wai Yee Ng; Mildred S Yang
Journal:  Chin Med       Date:  2008-07-11       Impact factor: 5.455

Review 10.  Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases.

Authors:  Haiping Zhao; Ziping Han; Guangwen Li; Sijia Zhang; Yumin Luo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.